No connection

Search Results

OABI vs OGI

OABI
OmniAb, Inc.
BEARISH
Price
$1.48
Market Cap
$214.3M
Sector
Healthcare
AI Confidence
80%
OGI
Organigram Global Inc.
BEARISH
Price
$1.52
Market Cap
$209.6M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
OABI
--
OGI
13.82
Forward P/E
OABI
-4.93
OGI
84.44
P/B Ratio
OABI
0.8
OGI
0.77
P/S Ratio
OABI
11.48
OGI
0.75
EV/EBITDA
OABI
-3.79
OGI
47.95

Profitability

Gross Margin
OABI
98.38%
OGI
35.61%
Operating Margin
OABI
-147.35%
OGI
-5.38%
Profit Margin
OABI
0.0%
OGI
6.49%
ROE
OABI
-23.36%
OGI
4.64%
ROA
OABI
-13.04%
OGI
-1.47%

Growth

Revenue Growth
OABI
-22.5%
OGI
48.7%
Earnings Growth
OABI
--
OGI
--

Financial Health

Debt/Equity
OABI
0.08
OGI
0.02
Current Ratio
OABI
4.02
OGI
2.73
Quick Ratio
OABI
3.78
OGI
0.62

Dividends

Dividend Yield
OABI
--
OGI
--
Payout Ratio
OABI
0.0%
OGI
0.0%

AI Verdict

OABI BEARISH

OABI presents a contradictory profile: while the Piotroski F-Score of 6/9 indicates stable financial health and the balance sheet is strong with low debt and high liquidity, the operational data is alarming. Revenue is declining sharply (-22.5% YoY), and the stock is in a severe technical downtrend with bearish insider activity from the CEO and CFO. Despite a 'Strong Buy' analyst consensus and a high price target, the fundamental divergence between shrinking top-line growth and high Price/Sales valuation suggests significant risk.

Strengths
Strong liquidity with a Current Ratio of 4.02
Very low leverage (Debt/Equity of 0.08)
Exceptional Gross Margins (98.38%)
Risks
Significant revenue contraction (-22.5% YoY)
Severe operating losses (Operating Margin -147.35%)
Strong bearish insider selling by key executives
OGI BEARISH

OGI exhibits severe financial fragility, highlighted by a weak Piotroski F-Score of 2/9 and a negative operating margin of -5.38%. While the stock appears undervalued relative to its Graham Number ($2.21) and Price-to-Book ratio (0.77), the intrinsic value is significantly lower at $0.77. Strong top-line revenue growth of 48.7% is currently offset by a poor earnings track record and a concerning spike in Forward P/E (from 13.82 to 84.44), suggesting a projected collapse in earnings. The company is essentially a speculative play on revenue growth that has yet to prove operational sustainability.

Strengths
Strong YoY revenue growth of 48.70%
Very low leverage with a Debt/Equity ratio of 0.02
Trading below book value (P/B 0.77)
Risks
Critical financial health weakness (Piotroski F-Score 2/9)
Negative operating margin (-5.38%) indicating core business losses
Severe earnings volatility with an average surprise of -949.02% over the last 4 quarters

Compare Another Pair

OABI vs OGI: Head-to-Head Comparison

This page compares OmniAb, Inc. (OABI) and Organigram Global Inc. (OGI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile